Skip to main content
Log in

Allopurinol and oxypurinol in human breast milk

  • Clinical Pharmacology Case Report
  • Published:
The clinical investigator Aims and scope Submit manuscript

Summary

To pregnant or breast feeding women drugs should be given with caution. We report the case of a 5-week-old breast-fed infant whose mother was taking 300 mg allopurinol/day for 4 weeks. Allopurinol and oxypurinol were detected by HPLC in maternal plasma and breast milk with a method first described here. In infant's plasma taken 2 h after breast feeding oxypurinol was found; allopurinol was below the limit of detection. The milk/plasma ratio in the mother 2 h (4 h) after drug ingestion was 0.9 (1.4) for allopurinol and 3.9 (2.4) for oxypurinol. The average daily dose for the baby of allopurinol was 0.14–0.20 mg/kg and that of oxypurinol 7.2–8.0 mg/kg by ingestion of breast milk after oral intake of allopurinol by the mother.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Appelbaum SJ, Mayersohn M, Dorr RT, Perrier D (1982) Allopurinol kinetics and bioavailability. Intravenous, oral and rectal administration. Cancer Chemother Pharmacol 14:789–791

    Google Scholar 

  2. Barrie H, Martin E, Ansell C (1975) Milk for babies. Lancet I:1330–1331

    Google Scholar 

  3. Berlin CM (1981) Pharmacological considerations of drug use in the lactating mother. Obstet Gynecol 58:17–23

    Google Scholar 

  4. Berlinger WG, Park DG, Spector R (1985) The effect of dietary protein on the clearance of allopurinol and oxypurinol. New Engl J Med 313:771–776

    Google Scholar 

  5. Betz AL (1985) Identification of hypoxanthine transport and xanthine oxidase activity in brain capillaries. J Neurochem 44:574–579

    Google Scholar 

  6. Breithaupt H, Goebel G (1981) Determination of allopurinol and oxipurinol in biological fluids by high-performance-liquid chromatography. J Chromatogr 226:237–242

    Google Scholar 

  7. Chaplin S, Sanders GL, Smith JM (1982) Drug excretion in human breast milk. Advances in Drug Reaction Ac Pois Rev 1:255–258

    Google Scholar 

  8. Elion GB, Lovensky A, Hitchings GH, Metz E, Rundles RW (1966) Metabolic studies of allopurinol, an inhibitor of xanthine oxidase. Biochem Pharmacol 15:836–880

    Google Scholar 

  9. Findlay JW (1983) The distribution of some commonly used drugs in human breast milk. Drug Metab Rev 14:653–684

    Google Scholar 

  10. Inset P (1990) Analgesic-antipyretic and antiinflammatory agents; drugs employed in the treatment of rheumatoid arthritis and gout. In: Goodman Gilman A, Rall T, Nies A, Taylor P (eds) The pharmacological basis of therapeutics, 8th edn. Pergamon Press, New York, pp 676–679

    Google Scholar 

  11. Jakobson I, Lindberg T (1979) Prospective study of cow's milk protein intolerance in Swedish infants. Acta Paediatr Scand 68:853–859

    Google Scholar 

  12. Jarasch ED, Grund C, Bruder G, Heid HW, Keenan TW (1981) Localisation of xanthine oxidase in mammary-gland epithelium and capillary endothelium. Cell 20:67–82

    Google Scholar 

  13. Kamilli I, Gresser U, Schaefer C, Zöllner N (1991) Allopurinol in breast milk. Adv Exp Med Biol 309A:143–145

    Google Scholar 

  14. Marks JF, Baum J, Keele DK, Kay JL, MacFarle A (1968) Lesch-Nyhan syndrome treated from the early neonatal period. Pediatrics 42:357–359

    Google Scholar 

  15. Modde H, Wedler E, Zacharias O (1961) Untersuchungen zur Frage der Wasserstoffionenkonzentration frischer Frauenmilch. Archiv für Gynäkology 196:343–358

    Google Scholar 

  16. Murell GAC, Rapeport WG (1986) Clinical pharmacokinetics of allopurinol. Clin Pharmacokinet 11:343–353

    Google Scholar 

  17. Platzker AC, Lew CD, Stewart D (1980) Drug administration via breast milk. Hosp Pract [Off] 15:111–122

    Google Scholar 

  18. Rao JM (1984) Drugs and breast feeding: avoiding complications. Current Therapy 25:55–58

    Google Scholar 

  19. Rasmussen F (1973) The mechanism of drug secretion into milk. In: Galli E (ed) Dietary lipids and postnatal development. Raven Press, New York, pp 231–245

    Google Scholar 

  20. Reisner SH, Eisenberg NH, Stahl B, Hauser GJ (1983) Maternal medication and breast feeding. Dev Pharmacol Ther 6:285–304

    Google Scholar 

  21. Schanker LS (1962) Passage of drugs across body membranes. Pharmacol Rev 14:501–502

    Google Scholar 

  22. Walter-Sack I, Gröbner W, Zöllner N (1979) Verlauf der Oxipurinol-Spiegel in Plasma nach akuter und chronischer Gabe von Allopurinol in verschiedenen galenischen Zubereitungen. Arzneimittelforschung 29 5:839–842

    Google Scholar 

  23. Wilson JT, Brown RO, Cherek DR (1980) Drug excretion in human breast milk. Principles, pharmacokinetics and projected consequences. Clin Pharmacokinet 5:1–66

    Google Scholar 

  24. Zöllner N, Gröbner W, Gresser U (1992) Purinstoffwechsel; Urikosurika, Urikostatika. Pharmakotherapie der Gicht. In: Forth W, Henschler D, Rummel W, Starke K (eds) Allgemeine und spezielle Pharmakologie und Toxikologie, 6th edn. BI Wissenschaftsverlag, Mannheim, pp 495–502

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Dedicated to Prof. Dr. N. Zöllner on the occasion of his 70th birthday

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kamilli, I., Gresser, U. Allopurinol and oxypurinol in human breast milk. Clin Investig 71, 161–164 (1993). https://doi.org/10.1007/BF00179999

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00179999

Key words

Navigation